首页> 外文期刊>Drugs of today: Medicamentos de actualidad >Cycling chemotherapy: A promising approach to reducing the morbidity and mortality of nosocomial infections.
【24h】

Cycling chemotherapy: A promising approach to reducing the morbidity and mortality of nosocomial infections.

机译:循环化学疗法:降低院内感染的发病率和死亡率的一种有前途的方法。

获取原文
获取原文并翻译 | 示例
           

摘要

In the past several decades, nosocomial infections have emerged as one of the most serious contributors to hospital morbidity and mortality, particularly amongst patients who require intensive care. Resistant organisms, both Gram-negative and Gram-positive, are now to blame for a significant portion of hospital-acquired infections. Efforts to prevent nosocomial infection had historically focused on infection control measures, such as patient isolation. However, there have been numerous reports of the increasing prevalence of antibiotic resistance, as well as the dramatic, negative impact of the infections they cause, both in terms of patient outcomes and attributable costs, demanding new methods to halt this growing epidemic. The increasing threat of resistance may be attributed in part to the widespread and increasingly inappropriate use of antimicrobials, which inadvertently exert sufficient effect on the hospital (and now community) environment to allow the preferential selection of resistant microbes. This idea of selective antibiotic pressure is supported by data showing volume of antibiotic use and inadequate antimicrobial coverage as risk factors for increased morbidity and mortality. Accordingly, the focus of nosocomial infection control has now largely shifted towards the judicious use of antibiotic therapy. There have been numerous attempts to curtail antibiotic usage through various forms of antibiotic stewardship: formulary restriction, computerized decision-support and abbreviated course empiric therapy. Aside from the inherent difficulty of effecting change in physician practice, we are burdened, particularly in the setting of empiric therapy, with the need to balance between adequate therapy for the individual and prudent drug selection so as not to endanger other patients in the environment through resistant organism selection. Cycling chemotherapy for empiric treatment of suspected infection is a method uniquely designed to address these challenges. (c) 2003 Prous Science. All rightsreserved.
机译:在过去的几十年中,医院感染已成为医院发病率和死亡率的最严重诱因之一,尤其是在需要重症监护的患者中。现在,很大一部分医院获得的感染都应归咎于革兰氏阴性和革兰氏阳性的耐药菌。预防医院感染的努力历来集中在感染控制措施上,例如患者隔离。但是,有许多报道表明,无论是从患者的预后还是在可归因的成本上,抗生素抗药性的流行率不断提高,以及它们引起的感染所产生的巨大的负面影响,都要求采取新的方法来制止这种流行病。抗药性威胁的增加可能部分归因于抗生素的广泛使用和日益不当使用,这无意间对医院(以及现在的社区)环境产生了足够的影响,从而允许优先选择抗药性微生物。选择性抗生素压力的想法得到了数据的支持,这些数据表明抗生素的使用量和不足的抗菌剂覆盖率是增加发病率和死亡率的危险因素。因此,现在医院感染控制的重点已大大转移到明智地使用抗生素治疗上。通过各种形式的抗生素管理来减少抗生素使用的尝试很多:配方限制,计算机决策支持和简短的经验治疗。除了改变医师执业的内在困难外,我们还承受了负担,尤其是在经验疗法方面,需要在针对个体的适当治疗与谨慎药物选择之间取得平衡,以免通过以下方式危害环境中的其他患者:抗性生物选择。循环化疗用于对可疑感染进行经验治疗是一种专门设计用于应对这些挑战的方法。 (c)2003 Prous科学。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号